3-Deazaneplanocin A (DZNep) hydrochloride

3-Deazaneplanocin A (DZNep) hydrochloride

Catalog Number:
L002369388APE
Mfr. No.:
APE-A8182
Price:
$459
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          3-Deazaneplanocin A (DZNep) hydrochloride is a selective inhibitor of ENZ2 inhibitor with IC50 value of 0.08-0.24 μM [1].ENZ2 is a sub-unit of PRC2 and plays an important role in regulating cell proliferation and cell-cycle progression. It has been reported that ENZ2 is over-expressed in many tumors, including prostate, breast, bladder cancers and AML [2]. In HepG2 cell lines, DZNep treatment markedly induced the intracellular lipids increasement and TNF-αand TGF-βexpression in mRNA level by augmenting PA/OA-dependent lipid accumulation [3].DZNep is a potent ENZ2 inhibitor. When tested with human acute myeloid leukemia (AML) HL-60 and OCI-AML3 cell lines, administration of DZNep induced cell apoptosis by depleting ENZ2, cyclin E and HOXA9 expressions and inducing p16, p21,p27 and FBXO32 expressions in a dose-dependent manner [2].In high-fat/high-fructose diet fed (HFa/HFr-D) rat mouse model that resembles human NAFLD metabolically and histologically, DZNep functioned as the effective agent to anti-inflammatory and anti-fibrotic roles by inhibiting ENZ2 [3]. It is also reported that DZNep has the inhibitory activity for (SAHH (S-adenosylhomocysteine hydrolase) with Ki value of 50 pM [4].

          [1]. Kikuchi, J., et al., Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells. Lung Cancer, 2012. 78(2): p. 138-43.
          [2]. Fiskus, W., et al., Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells. Blood, 2009. 114(13): p. 2733-43.
          [3]. Vella, S., et al., EZH2 down-regulation exacerbates lipid accumulation and inflammation in in vitro and in vivo NAFLD. Int J Mol Sci, 2013. 14(12): p. 24154-68.
          [4]. Glazer, R.I., et al., 3-Deazaneplanocin A: a new inhibitor of S-adenosylhomocysteine synthesis and its effects in human colon carcinoma cells. Biochem Pharmacol, 1986. 35(24): p. 4523-7.

      • Properties
        • Alternative Name
          NSC 617989 hydrochloride,DZNep,3-Deazaneplanocin A; (1S,2R,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-3-(hydroxymethyl)cyclopent-3-ene-1,2-diol;hydrochloride
          CAS Number
          120964-45-6
          Molecular Formula
          C12H14N4O3·HCl
          Molecular Weight
          298.73
          Appearance
          A solid
          Purity
          98.00%
          Solubility
          insoluble in EtOH; ≥14.94 mg/mL in DMSO; ≥18.32 mg/mL in H2O with ultrasonic
          Storage
          Store at -20°C

          * For Research Use Only

      • Reference
        • 1. Lin Xu , Jiandong Gao, et al. "Emodin ameliorates tubulointerstitial fibrosis in obstructed kidneys by inhibiting EZH2." Biochem Biophys Res Commun. 2020 Dec 4;S0006-291X(20)32138-0. PMID:33288199
          2. Hu W, Jia X, et al. "Chaetospirolactone reverses the apoptotic resistance towards TRAIL in pancreatic cancer." Biochem Biophys Res Commun. 2017 Oct 28. pii: S0006-291X(17)32129-0. PMID:29107694

    We Also Recommend

    SR 11302

    $352

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.